Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase 1 Study of Continuous OSI-906 Dosing

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				OSI-906-101 NCT00514007


2.		Phase 1 Study of Intermittent OSI-906 Dosing

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				OSI-906-102 NCT00514306


3.		A Phase 1 Dose-Escalation Study of OSI-906 and Erlotinib (Tarceva®)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Approved-not yet active				18 and over				Pharmaceutical / Industry				OSI-906-103 NCT00739453

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute